Cancer Prevention in Women With a BRCA Mutation

PHASE1UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2019

Conditions
BRCA1 Gene MutationBRCA2 Gene MutationBreast CancerOvarian Cancer
Interventions
BEHAVIORAL

Follow-up Telephone Genetic Counselling

Individualized theoretical genetic counselling among women with BRCA mutations to assess the impact it has on the uptake of cancer prevention strategies.

Trial Locations (3)

N6C 2R6

NOT_YET_RECRUITING

London Regional Cancer Centre, London

M5S 1B1

RECRUITING

Women's College Hospital, Toronto

M5T 2M9

NOT_YET_RECRUITING

Princess Margaret Hospital, Toronto

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

London Health Sciences Centre

OTHER

collaborator

Princess Margaret Hospital, Canada

OTHER

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

lead

Women's College Hospital

OTHER